Addex Therapeutics (ADXN.SW) Stock Overview
Addex Therapeutics Ltd., a biopharmaceutical firm specializing in allosteric modulators, experienced a decline in its share price during the 24‑hour period ending at 05:32 AM Central Europe on Thursday 22 October 2026. The stock closed at CHF 0.02, down 4.55 % from the previous session.
Market Metrics
| Item | Value |
|---|---|
| Current share price | CHF 0.02 |
| Shares outstanding | 127.6 million |
| Market capitalization | CHF 2.7 million |
| 24‑hour trading volume | CHF 4.9 k |
| 52‑week high | CHF 0.07 (21 Aug 2026) |
| 52‑week low | CHF 0.02 (2 Oct 2026) |
| 200‑day simple moving average | CHF 0.04 |
| Performance since last month‑end | -5.41 % |
Recent Price Action
- 24‑hour change: -4.55 %
- Month‑to‑date change: -5.41 %
- Lowest price recorded in the last 24 hours: CHF 0.02
- Highest price recorded in the last 24 hours: CHF 0.02
Peer Performance (Last 24 Hours)
| Stock | Ticker | 24‑hour change | Current price | Market capitalization |
|---|---|---|---|---|
| Ci Com | CIE.SW | 0 % | CHF 0.21 | CHF 76.7 k |
| Iq | IQL.F | +26.09 % | EUR 0.02 | EUR 771 k |
| Bebo Health | MLBBO.PA | 0 % | EUR 0.17 | EUR 365.4 k |
| Aethlon Medical | AEMD | +2.91 % | USD 5.07 | USD 3.7 mn |
| Senestech | SNES | -1.57 % | USD 0.75 | USD 3.8 mn |
Company Background
Addex Therapeutics Ltd. operates in the health care sector, focusing on the development of allosteric modulators for human health care applications. The company’s business model centers on researching, developing, and potentially commercializing therapeutic agents that modulate protein function through allosteric mechanisms.
This article presents factual information regarding Addex Therapeutics’ recent stock performance and related market data. No speculative commentary is included.
